Free Trial

Jack Henry & Associates (JKHY) Financials

Jack Henry & Associates logo
$135.09 -6.34 (-4.48%)
As of 12:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Jack Henry & Associates

Annual Income Statements for Jack Henry & Associates

This table shows Jack Henry & Associates' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
211 249 230 365 272 297 311 363 367 382 456
Consolidated Net Income / (Loss)
211 249 230 365 272 297 311 363 367 382 456
Net Income / (Loss) Continuing Operations
211 249 230 365 272 297 311 363 367 382 456
Total Pre-Tax Income
316 361 341 356 347 381 398 472 475 498 586
Total Operating Income
318 362 342 358 347 381 399 475 481 489 569
Total Gross Profit
536 581 582 618 630 689 695 814 859 916 1,015
Total Revenue
1,256 1,355 1,388 1,471 1,553 1,697 1,758 1,943 2,078 2,216 2,375
Operating Revenue
1,256 1,355 1,388 1,471 1,553 1,697 1,758 1,943 2,078 2,216 2,375
Total Cost of Revenue
720 774 806 853 923 1,008 1,063 1,129 1,219 1,299 1,361
Operating Cost of Revenue
720 774 806 853 923 1,008 1,063 1,129 1,219 1,299 1,361
Total Operating Expenses
218 219 241 260 282 308 296 340 378 427 446
Selling, General & Admin Expense
64 158 159 172 186 198 187 218 235 278 283
Research & Development Expense
71 81 85 90 96 110 109 121 143 148 163
Total Other Income / (Expense), net
-1.43 -1.12 -0.75 -2.69 -0.05 0.45 -0.99 -2.35 -6.11 8.63 17
Income Tax Expense
105 112 111 -8.88 75 84 86 109 108 116 130
Basic Earnings per Share
$2.60 $3.13 $2.95 $4.73 $3.52 $3.86 $4.12 $4.95 $5.03 $5.24 $6.25
Weighted Average Basic Shares Outstanding
81.35M 79.42M 77.86M 77.25M 77.16M 76.79M 75.55M 73.32M 72.92M 72.87M 72.87M
Diluted Earnings per Share
$2.59 $3.12 $2.93 $4.70 $3.52 $3.86 $4.12 $4.94 $5.02 $5.23 $6.24
Weighted Average Diluted Shares Outstanding
81.60M 79.73M 78.26M 77.59M 77.35M 76.93M 75.66M 73.49M 73.10M 73.03M 73.05M
Weighted Average Basic & Diluted Shares Outstanding
81.20M 79.50M 77.80M 77.18M 77.00M 76.64M 74.01M 72.90M 72.94M 72.91M 72.87M
Cash Dividends to Common per Share
$0.94 $1.06 $1.18 $1.36 $1.54 $1.66 $1.78 $1.90 $2.02 $2.14 $2.26

Quarterly Income Statements for Jack Henry & Associates

This table shows Jack Henry & Associates' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
102 92 87 101 119 98 111 128 144 125 123
Consolidated Net Income / (Loss)
102 92 87 101 119 98 111 128 144 125 123
Net Income / (Loss) Continuing Operations
102 92 87 101 119 98 111 128 144 125 123
Total Pre-Tax Income
133 120 114 130 157 127 142 160 190 164 159
Total Operating Income
133 119 112 126 151 123 139 156 184 159 155
Total Gross Profit
248 225 210 233 258 241 245 271 296 268 272
Total Revenue
571 546 539 560 601 574 585 615 645 619 636
Operating Revenue
571 546 539 560 601 574 585 615 645 619 636
Total Cost of Revenue
323 321 328 327 343 333 341 344 349 351 364
Operating Cost of Revenue
323 321 328 327 343 333 341 344 349 351 364
Total Operating Expenses
116 106 98 107 106 118 106 116 112 109 117
Selling, General & Admin Expense
79 70 62 67 67 77 66 73 73 67 72
Research & Development Expense
37 35 36 40 40 41 39 43 39 42 45
Total Other Income / (Expense), net
0.55 1.26 2.07 4.76 5.52 4.38 3.17 4.25 6.25 5.05 3.49
Income Tax Expense
32 28 27 29 38 30 31 32 46 40 36
Basic Earnings per Share
$1.40 $1.26 $1.20 $1.38 $1.63 $1.34 $1.53 $1.75 $1.98 $1.73 $1.71
Weighted Average Basic Shares Outstanding
72.87M 72.84M 72.87M 72.87M 72.91M 72.92M 72.85M 72.87M 72.75M 72.27M 71.77M
Diluted Earnings per Share
$1.39 $1.26 $1.19 $1.39 $1.63 $1.34 $1.52 $1.75 $1.97 $1.72 $1.71
Weighted Average Diluted Shares Outstanding
73.01M 72.98M 73.03M 73.03M 73.08M 73.08M 73.01M 73.05M 72.91M 72.41M 71.98M
Weighted Average Basic & Diluted Shares Outstanding
72.83M 72.87M 72.90M 72.91M 72.96M 72.90M 72.82M 72.87M 72.38M 72.17M 71.05M
Cash Dividends to Common per Share
$0.52 $0.52 $0.55 - $0.55 $0.55 $0.58 - $0.58 $0.58 $0.61

Annual Cash Flow Statements for Jack Henry & Associates

This table details how cash moves in and out of Jack Henry & Associates' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents
78 -78 44 -83 62 120 -162 -2.21 -37 26 64
Net Cash From Operating Activities
374 366 357 412 431 511 462 505 382 568 642
Net Cash From Continuing Operating Activities
374 366 357 412 431 511 462 505 382 568 642
Net Income / (Loss) Continuing Operations
211 249 230 365 272 297 311 363 367 382 456
Consolidated Net Income / (Loss)
211 249 230 365 272 297 311 363 367 382 456
Depreciation Expense
54 51 50 48 47 52 53 51 49 46 44
Amortization Expense
65 79 90 104 113 120 123 127 142 154 161
Non-Cash Adjustments To Reconcile Net Income
0.72 -6.17 16 11 13 46 19 25 24 33 30
Changes in Operating Assets and Liabilities, net
43 -5.93 -28 -116 -14 -4.14 -44 -61 -200 -46 -49
Net Cash From Investing Activities
-137 -136 -142 -292 -191 -198 -162 -196 -410 -240 -232
Net Cash From Continuing Investing Activities
-137 -136 -142 -292 -191 -198 -162 -196 -410 -240 -232
Purchase of Property, Plant & Equipment
-145 -165 -148 -137 -165 -171 -151 -183 -205 -225 -226
Acquisitions
0.00 -8.28 0.00 -151 -26 -37 -8.81 -8.49 -231 -7.13 -5.36
Purchase of Investments
- 0.00 0.00 -5.00 0.00 -1.15 -13 -5.00 -1.00 -8.65 -2.00
Sale of Property, Plant & Equipment
0.18 2.84 0.97 0.31 0.13 11 6.19 0.05 28 0.90 0.00
Sale and/or Maturity of Investments
- - - - 0.00 0.00 5.00 - 0.00 0.00 1.00
Net Cash From Financing Activities
-159 -308 -171 -204 -178 -193 -462 -310 -8.43 -302 -346
Net Cash From Continuing Financing Activities
-159 -308 -171 -204 -178 -193 -462 -310 -8.43 -302 -346
Repayment of Debt
-47 -153 -30 -175 -35 -55 -100 -317 -650 -600 -500
Repurchase of Common Equity
-123 -176 -130 -49 -55 -72 -432 -194 -25 -28 -35
Payment of Dividends
-76 -84 -92 -105 -119 -127 -134 -139 -147 -156 -165
Issuance of Debt
90 100 80 125 35 55 200 332 810 475 350
Issuance of Common Equity
4.88 5.71 6.25 7.52 9.04 9.83 11 12 12 12 12
Other Financing Activities, net
-7.31 -1.89 -5.48 -7.16 -14 -3.74 -7.72 -4.15 -8.50 -5.38 -7.72

Quarterly Cash Flow Statements for Jack Henry & Associates

This table details how cash moves in and out of Jack Henry & Associates' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
19 -4.76 0.55 11 4.93 -18 14 62 -66 -8.02 -7.64
Net Cash From Operating Activities
157 82 98 232 117 90 108 327 121 153 186
Net Cash From Continuing Operating Activities
157 82 98 232 117 90 108 327 121 153 186
Net Income / (Loss) Continuing Operations
102 92 87 101 119 98 111 128 144 125 123
Consolidated Net Income / (Loss)
102 92 87 101 119 98 111 128 144 125 123
Depreciation Expense
12 12 11 11 11 11 10 11 10 10 10
Amortization Expense
37 38 39 39 39 40 41 41 41 43 43
Non-Cash Adjustments To Reconcile Net Income
7.04 8.66 6.98 10 6.68 8.86 6.88 7.95 2.51 6.91 12
Changes in Operating Assets and Liabilities, net
-0.81 -69 -47 70 -59 -69 -61 140 -78 -32 -2.61
Net Cash From Investing Activities
-51 -60 -54 -76 -59 -61 -57 -56 -99 -57 -64
Net Cash From Continuing Investing Activities
-51 -60 -54 -76 -59 -61 -57 -56 -99 -57 -64
Purchase of Property, Plant & Equipment
-49 -59 -52 -66 -55 -60 -56 -54 -57 -65 -64
Acquisitions
-2.28 -0.69 -1.59 -2.57 -2.68 -0.85 -0.31 -1.53 -44 -1.40 -0.09
Purchase of Investments
0.00 -1.00 -0.15 -7.50 -2.00 - - - -6.00 -7.50 -0.21
Net Cash From Financing Activities
-87 -26 -43 -145 -53 -46 -37 -209 -88 -103 -129
Net Cash From Continuing Financing Activities
-87 -26 -43 -145 -53 -46 -37 -209 -88 -103 -129
Repayment of Debt
-165 -75 -120 -240 -85 -80 -70 -265 0.00 -105 -165
Repurchase of Common Equity
-20 - - -8.06 0.00 -17 -18 0.00 -62 -63 -159
Payment of Dividends
-38 -38 -40 -40 -40 -40 -42 -42 -42 -42 -43
Issuance of Debt
135 85 115 140 75 90 90 95 20 105 235
Issuance of Common Equity
3.42 2.62 3.37 3.07 3.04 2.17 3.48 3.06 3.09 1.92 3.46
Other Financing Activities, net
-2.94 -0.62 -1.78 -0.04 -6.17 -1.17 -0.32 -0.07 -6.71 -0.28 -0.14

Annual Balance Sheets for Jack Henry & Associates

This table presents Jack Henry & Associates' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets
1,837 1,816 90 2,648 2,185 2,428 2,336 2,456 2,774 2,924 3,044
Total Current Assets
493 432 0.00 471 569 669 544 614 628 632 681
Cash & Equivalents
148 70 - 31 94 213 51 49 12 38 102
Accounts Receivable
245 254 - 297 310 301 307 348 361 333 318
Inventories, net
- - - - - - 0.00 20 - 0.00 5.61
Prepaid Expenses
69 57 - 96 106 96 110 126 169 169 180
Current Deferred & Refundable Income Taxes
2.75 16 - 22 18 21 30 14 7.52 6.15 0.00
Other Current Assets
28 35 - 24 41 38 46 57 78 86 76
Plant, Property, & Equipment, net
296 299 0.00 286 272 273 252 212 206 215 221
Total Noncurrent Assets
1,047 1,085 90 1,892 1,343 1,486 1,540 1,630 1,940 2,077 2,142
Goodwill
550 553 - 650 667 686 687 687 805 805 805
Intangible Assets
348 362 90 941 451 465 476 506 651 672 685
Other Noncurrent Operating Assets
149 170 - 300 225 334 376 437 484 601 651
Total Liabilities & Shareholders' Equity
1,837 1,816 0.00 2,033 2,185 2,428 2,336 2,456 2,774 2,924 3,044
Total Liabilities
845 819 0.00 710 756 879 1,017 1,074 1,165 1,082 913
Total Current Liabilities
444 444 0.00 448 470 495 521 544 524 634 536
Accounts Payable
9.93 15 - 30 9.85 9.88 18 21 19 25 28
Accrued Expenses
79 85 - 89 120 167 183 192 173 201 207
Current Deferred Revenue
340 344 - 329 340 318 320 331 332 318 290
Current Deferred & Payable Income Tax Liabilities
13 0.00 - - - - - - - 0.00 9.68
Total Noncurrent Liabilities
402 376 0.00 262 286 384 496 530 642 448 377
Long-Term Debt
50 0.00 - - 0.00 0.21 100 115 275 60 0.00
Noncurrent Deferred Revenue
192 178 - 41 55 71 76 71 68 71 73
Noncurrent Deferred & Payable Income Tax Liabilities
150 189 - 208 217 244 261 293 244 244 240
Other Noncurrent Operating Liabilities
8.92 9.44 - 13 14 68 59 51 54 74 64
Total Equity & Noncontrolling Interests
992 996 0.00 1,323 1,429 1,550 1,319 1,382 1,609 1,842 2,131
Total Preferred & Common Equity
992 996 0.00 1,323 1,429 1,550 1,319 1,382 1,609 1,842 2,131
Preferred Stock
0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
992 996 0.00 1,323 1,429 1,550 1,319 1,382 1,609 1,842 2,131
Common Stock
426 441 - 465 473 496 520 552 585 621 653
Retained Earnings
1,266 1,431 - 1,913 2,066 2,235 2,412 2,636 2,856 3,082 3,373
Treasury Stock
-700 -876 - -1,055 -1,110 -1,182 -1,613 -1,807 -1,832 -1,860 -1,895

Quarterly Balance Sheets for Jack Henry & Associates

This table presents Jack Henry & Associates' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets
2,774 2,734 2,754 2,770 2,924 2,929 2,912 2,932 3,048 3,060 3,051
Total Current Assets
628 563 554 523 632 635 580 593 652 616 595
Cash & Equivalents
12 31 27 27 38 43 26 40 36 28 21
Accounts Receivable
361 289 271 263 333 307 283 282 308 298 282
Inventories, net
- - - - - 10 - - 11 0.00 5.73
Prepaid Expenses
169 164 179 159 169 191 190 188 211 202 201
Current Deferred & Refundable Income Taxes
7.52 0.00 0.00 0.00 6.15 0.00 0.00 0.00 0.78 2.43 3.53
Other Current Assets
78 80 78 73 86 84 81 83 85 85 81
Plant, Property, & Equipment, net
206 203 205 216 215 212 227 222 205 215 214
Total Noncurrent Assets
1,940 1,968 1,995 2,032 2,077 2,082 2,105 2,117 2,191 2,229 2,242
Goodwill
805 805 805 805 805 805 805 805 827 828 828
Intangible Assets
651 658 662 667 672 676 680 684 713 712 715
Other Noncurrent Operating Assets
484 505 528 561 601 601 620 628 651 689 699
Total Liabilities & Shareholders' Equity
2,774 2,734 2,754 2,770 2,924 2,929 2,912 2,932 3,048 3,060 3,051
Total Liabilities
1,165 1,074 1,030 991 1,082 1,003 936 896 874 857 916
Total Current Liabilities
524 471 404 375 634 571 497 436 436 385 341
Accounts Payable
19 20 19 27 25 20 24 13 18 18 20
Accrued Expenses
173 158 174 180 201 180 186 184 173 174 192
Current Deferred Revenue
332 262 197 147 318 249 197 144 245 193 129
Current Deferred & Payable Income Tax Liabilities
- 31 14 20 0.00 31 0.28 4.23 0.00 0.00 0.00
Total Noncurrent Liabilities
642 604 626 616 448 433 439 460 438 472 575
Long-Term Debt
275 245 255 250 60 50 60 80 20 20 90
Noncurrent Deferred Revenue
68 72 72 67 71 71 72 78 76 78 80
Noncurrent Deferred & Payable Income Tax Liabilities
244 234 228 229 244 239 235 231 279 310 340
Other Noncurrent Operating Liabilities
54 53 70 70 74 73 72 72 63 64 64
Total Equity & Noncontrolling Interests
1,609 1,660 1,724 1,780 1,842 1,925 1,976 2,036 2,173 2,203 2,135
Total Preferred & Common Equity
1,609 1,660 1,724 1,780 1,842 1,925 1,976 2,036 2,173 2,203 2,135
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,609 1,660 1,724 1,780 1,842 1,925 1,976 2,036 2,173 2,203 2,135
Common Stock
585 592 603 611 621 624 634 644 656 666 678
Retained Earnings
2,856 2,920 2,974 3,021 3,082 3,161 3,219 3,287 3,475 3,557 3,637
Treasury Stock
-1,832 -1,852 -1,852 -1,852 -1,860 -1,860 -1,877 -1,895 -1,957 -2,020 -2,180

Annual Metrics And Ratios for Jack Henry & Associates

This table displays calculated financial ratios and metrics derived from Jack Henry & Associates' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.08% 7.84% 2.48% 5.94% 5.57% 9.30% 3.60% 10.50% 6.94% 6.63% 7.21%
EBITDA Growth
10.30% 12.46% -2.00% 5.81% -0.31% 8.76% 3.99% 13.54% 2.94% 2.66% 12.21%
EBIT Growth
10.26% 13.78% -5.51% 4.62% -2.86% 9.60% 4.75% 19.04% 1.28% 1.81% 16.21%
NOPAT Growth
13.35% 17.66% -7.84% 59.27% -25.79% 8.97% 5.38% 16.81% 1.82% 1.03% 17.88%
Net Income Growth
13.12% 17.82% -7.76% 59.01% -25.52% 9.12% 4.99% 16.52% 1.03% 4.14% 19.36%
EPS Growth
18.26% 20.46% -6.09% 60.41% -25.11% 9.66% 6.74% 19.90% 1.62% 4.18% 19.31%
Operating Cash Flow Growth
9.40% -1.97% -2.48% 15.34% 4.61% 18.42% -9.48% 9.20% -24.39% 48.87% 12.93%
Free Cash Flow Firm Growth
20.71% -1.32% 385.62% -236.00% 158.15% -64.99% -4.95% 1.74% -118.22% 662.35% 25.68%
Invested Capital Growth
-1.13% 3.37% -90.24% 2,007.88% -29.95% 0.10% 2.38% 5.80% 29.24% 4.43% 3.83%
Revenue Q/Q Growth
2.99% 2.52% -1.84% 2.60% 0.99% 1.01% 2.31% 1.70% 2.57% 1.15% 2.39%
EBITDA Q/Q Growth
4.51% 6.91% -8.15% 3.32% -0.77% -0.02% 3.50% 1.31% 3.72% 0.55% 4.16%
EBIT Q/Q Growth
5.72% 8.11% -11.30% 3.47% -1.57% -0.68% 5.14% 1.60% 4.44% 0.29% 5.58%
NOPAT Q/Q Growth
7.39% 10.56% -13.48% 5.67% -2.56% 0.09% 5.37% 1.06% 4.74% -0.14% 6.45%
Net Income Q/Q Growth
7.41% 10.54% -13.49% 5.61% -2.45% 0.12% 5.24% 0.99% 4.97% 0.87% 6.18%
EPS Q/Q Growth
7.92% 11.43% -13.06% 5.62% -2.22% 0.26% 6.19% 1.23% 5.02% 0.97% 6.12%
Operating Cash Flow Q/Q Growth
3.06% -8.09% -0.17% 4.78% 4.99% 7.66% -7.65% 1.49% -7.00% 11.21% 17.45%
Free Cash Flow Firm Q/Q Growth
-24.37% 3.53% 340.74% -215.93% 181.76% 12.58% -9.65% -2.47% -184.57% 12.54% 46.07%
Invested Capital Q/Q Growth
-8.70% -6.93% -91.13% 1,546.70% -6.33% -8.42% -5.33% -4.36% -0.82% -2.43% -6.35%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.66% 42.89% 41.95% 41.99% 40.55% 40.58% 39.52% 41.91% 41.33% 41.35% 42.71%
EBITDA Margin
34.78% 36.27% 34.68% 34.64% 32.71% 32.55% 32.67% 33.57% 32.32% 31.11% 32.56%
Operating Margin
25.30% 26.70% 24.61% 24.31% 22.37% 22.43% 22.68% 24.43% 23.14% 22.09% 23.94%
EBIT Margin
25.30% 26.70% 24.61% 24.31% 22.37% 22.43% 22.68% 24.43% 23.14% 22.09% 23.94%
Profit (Net Income) Margin
16.81% 18.37% 16.54% 24.82% 17.51% 17.48% 17.72% 18.68% 17.65% 17.23% 19.19%
Tax Burden Percent
66.75% 69.03% 67.33% 102.49% 78.30% 77.85% 78.31% 76.85% 77.26% 76.67% 77.77%
Interest Burden Percent
99.55% 99.69% 99.78% 99.62% 99.99% 100.12% 99.75% 99.50% 98.73% 101.76% 103.05%
Effective Tax Rate
33.25% 30.97% 32.67% -2.49% 21.70% 22.15% 21.69% 23.15% 22.74% 23.33% 22.23%
Return on Invested Capital (ROIC)
23.55% 27.40% 45.26% 36.70% 16.78% 22.18% 23.09% 25.90% 22.38% 19.62% 22.21%
ROIC Less NNEP Spread (ROIC-NNEP)
24.76% 28.34% 40.31% 36.29% 16.76% 21.95% 24.04% 22.77% 19.51% 23.15% 298.15%
Return on Net Nonoperating Assets (RNNOA)
-1.98% -2.36% 0.82% 18.49% 2.98% -2.26% -1.37% 0.97% 2.15% 2.51% 0.73%
Return on Equity (ROE)
21.57% 25.04% 46.09% 55.19% 19.76% 19.92% 21.71% 26.87% 24.52% 22.13% 22.94%
Cash Return on Invested Capital (CROIC)
24.68% 24.09% 209.68% -145.18% 52.00% 22.08% 20.73% 20.26% -3.13% 15.29% 18.45%
Operating Return on Assets (OROA)
18.07% 19.80% 35.86% 26.11% 14.37% 16.50% 16.74% 19.81% 18.38% 17.18% 19.06%
Return on Assets (ROA)
12.01% 13.63% 24.09% 26.66% 11.25% 12.86% 13.07% 15.15% 14.02% 13.40% 15.27%
Return on Common Equity (ROCE)
21.57% 25.04% 46.09% 55.19% 19.76% 19.92% 21.71% 26.87% 24.52% 22.13% 22.94%
Return on Equity Simple (ROE_SIMPLE)
21.30% 24.98% 0.00% 27.59% 19.03% 19.14% 23.61% 26.27% 22.79% 20.72% 0.00%
Net Operating Profit after Tax (NOPAT)
212 250 230 366 272 296 312 365 371 375 442
NOPAT Margin
16.89% 18.43% 16.57% 24.91% 17.51% 17.46% 17.76% 18.77% 17.87% 16.94% 18.62%
Net Nonoperating Expense Percent (NNEP)
-1.21% -0.94% 4.96% 0.41% 0.02% 0.23% -0.95% 3.13% 2.87% -3.53% -275.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 20.76%
Cost of Revenue to Revenue
57.34% 57.11% 58.05% 58.01% 59.45% 59.42% 60.48% 58.09% 58.67% 58.65% 57.29%
SG&A Expenses to Revenue
5.12% 11.63% 11.47% 11.67% 11.98% 11.67% 10.64% 11.24% 11.32% 12.57% 11.92%
R&D to Revenue
5.69% 6.00% 6.10% 6.14% 6.21% 6.48% 6.20% 6.25% 6.87% 6.69% 6.85%
Operating Expenses to Revenue
17.35% 16.19% 17.34% 17.69% 18.19% 18.15% 16.84% 17.48% 18.19% 19.26% 18.77%
Earnings before Interest and Taxes (EBIT)
318 362 342 358 347 381 399 475 481 489 569
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
437 491 482 509 508 552 574 652 671 689 773
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.75 6.29 0.00 7.11 6.83 8.68 8.88 9.26 7.48 6.57 6.16
Price to Tangible Book Value (P/TBV)
50.41 76.98 0.00 0.00 31.38 33.79 75.21 67.84 78.93 33.08 20.47
Price to Revenue (P/Rev)
3.75 4.63 5.36 6.39 6.28 7.92 6.66 6.58 5.79 5.46 5.52
Price to Earnings (P/E)
22.29 25.19 32.41 25.77 35.89 45.32 37.61 35.25 32.82 31.70 28.79
Dividend Yield
1.62% 1.33% 1.23% 1.12% 1.22% 0.95% 1.13% 1.08% 1.22% 1.29% 1.25%
Earnings Yield
4.49% 3.97% 3.09% 3.88% 2.79% 2.21% 2.66% 2.84% 3.05% 3.15% 3.47%
Enterprise Value to Invested Capital (EV/IC)
5.15 6.69 82.27 4.92 7.24 9.90 8.60 8.88 6.57 6.25 6.42
Enterprise Value to Revenue (EV/Rev)
3.67 4.58 5.36 6.37 6.22 7.80 6.69 6.62 5.92 5.51 5.48
Enterprise Value to EBITDA (EV/EBITDA)
10.56 12.62 15.45 18.40 19.03 23.95 20.48 19.71 18.32 17.72 16.83
Enterprise Value to EBIT (EV/EBIT)
14.51 17.14 21.77 26.22 27.83 34.77 29.51 27.09 25.58 24.96 22.89
Enterprise Value to NOPAT (EV/NOPAT)
21.74 24.83 32.34 25.58 35.54 44.66 37.68 35.26 33.11 32.55 29.43
Enterprise Value to Operating Cash Flow (EV/OCF)
12.34 16.92 20.82 22.74 22.41 25.92 25.46 25.48 32.23 21.50 20.29
Enterprise Value to Free Cash Flow (EV/FCFF)
20.74 28.25 6.98 0.00 11.47 44.85 41.95 45.07 0.00 41.78 35.42
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.05 0.00 0.00 0.00 0.00 0.00 0.08 0.08 0.17 0.08 0.00
Long-Term Debt to Equity
0.05 0.00 0.00 0.00 0.00 0.00 0.08 0.08 0.17 0.03 0.00
Financial Leverage
-0.08 -0.08 0.02 0.51 0.18 -0.10 -0.06 0.04 0.11 0.11 0.00
Leverage Ratio
1.80 1.84 1.91 2.07 1.76 1.55 1.66 1.77 1.75 1.65 1.50
Compound Leverage Factor
1.79 1.83 1.91 2.06 1.76 1.55 1.66 1.77 1.73 1.68 1.55
Debt to Total Capital
5.05% 0.02% 0.00% 0.00% 0.00% 0.02% 7.06% 7.69% 14.60% 7.53% 0.00%
Short-Term Debt to Total Capital
0.25% 0.02% 0.00% 0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 4.52% 0.00%
Long-Term Debt to Total Capital
4.80% 0.00% 0.00% 0.00% 0.00% 0.01% 7.05% 7.68% 14.60% 3.01% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
94.95% 99.98% 0.00% 100.00% 100.00% 99.98% 92.94% 92.31% 85.40% 92.47% 100.00%
Debt to EBITDA
0.12 0.00 0.00 0.00 0.00 0.00 0.17 0.18 0.41 0.22 0.00
Net Debt to EBITDA
-0.22 -0.14 0.00 0.00 0.00 -0.39 0.09 0.10 0.39 0.16 0.00
Long-Term Debt to EBITDA
0.11 0.00 0.00 0.00 0.00 0.00 0.17 0.18 0.41 0.09 0.00
Debt to NOPAT
0.25 0.00 0.00 0.00 0.00 0.00 0.32 0.32 0.74 0.40 0.00
Net Debt to NOPAT
-0.45 -0.28 0.00 0.00 0.00 -0.72 0.16 0.18 0.71 0.30 0.00
Long-Term Debt to NOPAT
0.24 0.00 0.00 0.00 0.00 0.00 0.32 0.32 0.74 0.16 0.00
Altman Z-Score
5.59 7.09 0.00 9.97 10.36 11.77 9.69 10.11 9.00 9.50 11.63
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.11 0.97 0.00 1.05 1.21 1.35 1.04 1.13 1.20 1.00 1.27
Quick Ratio
0.89 0.73 0.00 0.73 0.86 1.04 0.69 0.73 0.71 0.59 0.78
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
222 219 1,066 -1,449 843 295 280 285 -52 292 367
Operating Cash Flow to CapEx
257.57% 226.58% 242.72% 301.99% 261.95% 319.74% 318.39% 275.98% 215.13% 253.15% 284.10%
Free Cash Flow to Firm to Interest Expense
139.52 153.47 1,070.01 -443.91 910.10 428.83 245.12 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
234.50 256.24 358.76 126.23 465.58 742.05 403.96 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
143.46 143.15 210.95 84.43 287.84 509.97 277.08 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.71 0.74 1.46 1.07 0.64 0.74 0.74 0.81 0.79 0.78 0.80
Accounts Receivable Turnover
5.35 5.43 0.00 0.00 5.11 5.55 5.79 5.94 5.86 6.38 7.30
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.27 4.55 0.00 0.00 5.57 6.22 6.69 8.37 9.96 10.53 10.90
Accounts Payable Turnover
70.45 63.08 0.00 0.00 45.91 102.23 74.98 57.12 60.66 58.44 50.87
Days Sales Outstanding (DSO)
68.20 67.27 0.00 0.00 71.39 65.71 63.06 61.49 62.31 57.19 50.02
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
5.18 5.79 0.00 0.00 7.95 3.57 4.87 6.39 6.02 6.25 7.18
Cash Conversion Cycle (CCC)
63.02 61.48 0.00 0.00 63.44 62.14 58.19 55.10 56.29 50.94 42.84
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
896 926 90 1,906 1,335 1,337 1,368 1,448 1,871 1,954 2,029
Invested Capital Turnover
1.39 1.49 2.73 1.47 0.96 1.27 1.30 1.38 1.25 1.16 1.19
Increase / (Decrease) in Invested Capital
-10 30 -836 1,816 -571 1.28 32 79 423 83 75
Enterprise Value (EV)
4,612 6,200 7,440 9,374 9,663 13,232 11,764 12,859 12,298 12,215 13,017
Market Capitalization
4,707 6,270 7,440 9,405 9,757 13,446 11,715 12,792 12,035 12,103 13,119
Book Value per Share
$12.24 $12.63 $0.00 $17.11 $18.51 $20.23 $17.76 $18.96 $22.07 $25.27 $29.26
Tangible Book Value per Share
$1.15 $1.03 ($1.16) ($3.47) $4.03 $5.19 $2.10 $2.59 $2.09 $5.02 $8.80
Total Capital
1,044 996 0.00 1,323 1,429 1,550 1,419 1,497 1,884 1,992 2,131
Total Debt
53 0.20 0.00 0.00 0.00 0.32 100 115 275 150 0.00
Total Long-Term Debt
50 0.00 0.00 0.00 0.00 0.21 100 115 275 60 0.00
Net Debt
-96 -70 0.00 -31 -94 -213 49 66 263 112 -102
Capital Expenditures (CapEx)
145 162 147 136 165 160 145 183 177 224 226
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-96 -82 0.00 -8.75 5.86 -39 -28 21 92 50 44
Debt-free Net Working Capital (DFNWC)
52 -12 0.00 23 99 174 23 70 104 88 146
Net Working Capital (NWC)
50 -12 0.00 23 99 174 23 70 104 -1.80 146
Net Nonoperating Expense (NNE)
0.95 0.78 0.50 1.38 0.04 -0.35 0.78 1.81 4.72 -6.61 -13
Net Nonoperating Obligations (NNO)
-96 -70 90 583 -94 -213 49 66 263 112 -102
Total Depreciation and Amortization (D&A)
119 130 140 152 161 172 176 178 191 200 205
Debt-free, Cash-free Net Working Capital to Revenue
-7.63% -6.05% 0.00% -0.60% 0.38% -2.30% -1.59% 1.08% 4.43% 2.25% 1.84%
Debt-free Net Working Capital to Revenue
4.18% -0.86% 0.00% 1.54% 6.41% 10.27% 1.31% 3.59% 5.02% 3.98% 6.13%
Net Working Capital to Revenue
3.97% -0.87% 0.00% 1.54% 6.41% 10.27% 1.30% 3.59% 5.02% -0.08% 6.13%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.52 $3.86 $4.12 $4.95 $5.03 $5.24 $6.25
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 77.16M 76.79M 75.55M 73.32M 72.92M 72.87M 72.87M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $3.52 $3.86 $4.12 $4.94 $5.02 $5.23 $6.24
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 77.35M 76.93M 75.66M 73.49M 73.10M 73.03M 73.05M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 77.00M 76.64M 74.01M 72.90M 72.94M 72.91M 72.87M
Normalized Net Operating Profit after Tax (NOPAT)
212 250 230 250 272 296 312 365 371 375 442
Normalized NOPAT Margin
16.89% 18.43% 16.57% 17.01% 17.51% 17.46% 17.76% 18.77% 17.87% 16.94% 18.62%
Pre Tax Income Margin
25.19% 26.61% 24.56% 24.22% 22.36% 22.46% 22.62% 24.31% 22.84% 22.48% 24.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
199.41 252.91 343.09 109.50 375.04 553.24 348.53 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
133.11 174.57 230.99 112.22 293.65 430.70 272.94 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
108.37 139.82 195.28 67.70 197.30 321.16 221.66 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
42.07 61.49 83.18 70.42 115.92 198.62 146.07 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
36.18% 33.80% 39.95% 28.77% 43.67% 42.95% 42.96% 38.32% 40.16% 40.83% 36.13%
Augmented Payout Ratio
94.26% 104.39% 96.64% 42.19% 63.85% 67.07% 181.50% 91.75% 46.98% 48.17% 43.82%

Quarterly Metrics And Ratios for Jack Henry & Associates

This table displays calculated financial ratios and metrics derived from Jack Henry & Associates' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 72,167,368.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 72,167,368.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.70
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.97% 7.99% 5.90% 4.73% 5.18% 5.16% 8.64% 9.90% 7.28% 7.93% 8.74%
EBITDA Growth
-2.36% 8.61% 3.28% 2.17% 10.90% 3.49% 17.00% 17.51% 16.94% 21.49% 9.99%
EBIT Growth
-5.70% 10.79% 3.42% 1.15% 14.00% 3.39% 23.77% 23.94% 21.68% 29.39% 11.75%
NOPAT Growth
-5.92% 10.39% 2.67% -0.60% 13.56% 3.82% 27.02% 27.55% 21.10% 27.90% 10.64%
Net Income Growth
-4.57% 13.85% 6.81% 3.38% 17.22% 6.39% 27.57% 26.25% 20.80% 27.41% 10.61%
EPS Growth
-4.79% 14.55% 6.25% 3.73% 17.27% 6.35% 27.73% 25.90% 20.86% 28.36% 12.50%
Operating Cash Flow Growth
14.84% 51.32% 497.86% 32.81% -25.61% 9.95% 10.54% 41.12% 3.16% 70.29% 72.49%
Free Cash Flow Firm Growth
34.66% 47.93% 89.50% 104.48% 65.98% 47.99% -81.79% 239.10% 111.93% 149.11% 249.32%
Invested Capital Growth
11.90% 10.93% 6.14% 4.43% 7.92% 7.54% 8.18% 3.83% 6.69% 4.52% 1.74%
Revenue Q/Q Growth
6.87% -4.49% -1.31% 3.96% 7.34% -4.51% 1.96% 5.18% 4.77% -3.94% 2.73%
EBITDA Q/Q Growth
5.42% -7.19% -3.96% 8.72% 14.44% -13.39% 8.58% 9.19% 13.89% -10.02% -1.70%
EBIT Q/Q Growth
6.84% -10.35% -5.77% 12.07% 20.42% -18.69% 12.79% 12.22% 18.22% -13.54% -2.58%
NOPAT Q/Q Growth
3.36% -10.13% -6.02% 13.87% 18.08% -17.84% 14.97% 14.35% 12.11% -13.23% -0.54%
Net Income Q/Q Growth
4.00% -9.55% -5.29% 16.04% 17.93% -17.91% 13.56% 14.85% 12.84% -13.42% -1.42%
EPS Q/Q Growth
3.73% -9.35% -5.56% 16.81% 17.27% -17.79% 13.43% 15.13% 12.57% -12.69% -0.58%
Operating Cash Flow Q/Q Growth
-9.96% -48.11% 19.67% 137.57% -49.57% -23.31% 20.30% 203.31% -63.14% 26.60% 21.86%
Free Cash Flow Firm Q/Q Growth
69.88% -3.48% 70.03% 147.94% -328.81% -58.22% -4.75% 189.42% -91.95% 551.55% 218.47%
Invested Capital Q/Q Growth
0.12% 4.23% 2.56% -2.43% 3.47% 3.86% 3.17% -6.35% 6.32% 1.75% 0.43%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.47% 41.18% 39.06% 41.55% 42.85% 42.00% 41.79% 44.12% 45.94% 43.33% 42.80%
EBITDA Margin
31.84% 30.94% 30.11% 31.49% 33.57% 30.45% 32.43% 33.67% 36.60% 34.28% 32.80%
Operating Margin
23.23% 21.80% 20.81% 22.44% 25.17% 21.43% 23.71% 25.30% 28.55% 25.70% 24.37%
EBIT Margin
23.23% 21.80% 20.81% 22.44% 25.17% 21.43% 23.71% 25.30% 28.55% 25.70% 24.37%
Profit (Net Income) Margin
17.80% 16.85% 16.17% 18.05% 19.83% 17.05% 18.99% 20.74% 22.33% 20.13% 19.32%
Tax Burden Percent
76.31% 76.50% 76.29% 77.52% 76.02% 76.81% 78.30% 79.78% 75.66% 75.93% 77.52%
Interest Burden Percent
100.41% 101.06% 101.84% 103.79% 103.65% 103.56% 102.28% 102.73% 103.40% 103.17% 102.25%
Effective Tax Rate
23.69% 23.50% 23.71% 22.48% 23.98% 23.19% 21.70% 20.22% 24.34% 24.07% 22.48%
Return on Invested Capital (ROIC)
21.18% 19.41% 17.88% 20.15% 22.06% 18.47% 20.66% 24.08% 25.01% 22.39% 21.74%
ROIC Less NNEP Spread (ROIC-NNEP)
21.38% 19.81% 18.44% 22.12% 24.76% 20.38% 22.07% 93.57% 36.75% 28.99% 24.46%
Return on Net Nonoperating Assets (RNNOA)
2.92% 2.92% 3.17% 2.40% 2.14% 1.94% 2.04% 0.23% 0.72% 0.81% 1.17%
Return on Equity (ROE)
24.10% 22.33% 21.06% 22.55% 24.20% 20.41% 22.70% 24.30% 25.73% 23.20% 22.91%
Cash Return on Invested Capital (CROIC)
9.34% 9.75% 13.36% 15.29% 12.35% 12.10% 12.07% 18.45% 15.85% 18.53% 21.36%
Operating Return on Assets (OROA)
18.53% 17.66% 16.95% 17.45% 19.96% 17.20% 19.29% 20.14% 23.11% 21.21% 20.49%
Return on Assets (ROA)
14.20% 13.66% 13.17% 14.04% 15.73% 13.68% 15.45% 16.50% 18.08% 16.61% 16.24%
Return on Common Equity (ROCE)
24.10% 22.33% 21.06% 22.55% 24.20% 20.41% 22.70% 24.30% 25.73% 23.20% 22.91%
Return on Equity Simple (ROE_SIMPLE)
21.79% 21.63% 21.27% 0.00% 20.74% 20.51% 21.08% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
101 91 86 97 115 94 109 124 139 121 120
NOPAT Margin
17.72% 16.68% 15.88% 17.39% 19.13% 16.46% 18.57% 20.18% 21.60% 19.51% 18.89%
Net Nonoperating Expense Percent (NNEP)
-0.20% -0.40% -0.55% -1.97% -2.71% -1.91% -1.41% -69.49% -11.75% -6.60% -2.71%
Return On Investment Capital (ROIC_SIMPLE)
- 4.60% - - - 4.45% 4.92% 5.83% 6.35% 5.44% 5.40%
Cost of Revenue to Revenue
56.53% 58.82% 60.94% 58.45% 57.15% 58.00% 58.21% 55.88% 54.06% 56.67% 57.20%
SG&A Expenses to Revenue
13.79% 12.88% 11.56% 11.99% 11.08% 13.40% 11.34% 11.90% 11.30% 10.81% 11.34%
R&D to Revenue
6.46% 6.50% 6.68% 7.12% 6.60% 7.16% 6.74% 6.92% 6.09% 6.82% 7.09%
Operating Expenses to Revenue
20.24% 19.38% 18.24% 19.11% 17.68% 20.56% 18.08% 18.82% 17.39% 17.63% 18.43%
Earnings before Interest and Taxes (EBIT)
133 119 112 126 151 123 139 156 184 159 155
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
182 169 162 176 202 175 190 207 236 212 209
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.56 6.81 7.09 6.57 6.69 6.47 6.54 6.16 4.99 6.00 5.34
Price to Tangible Book Value (P/TBV)
55.17 45.62 40.89 33.08 28.99 26.07 24.31 20.47 17.14 19.92 19.25
Price to Revenue (P/Rev)
5.13 5.44 5.76 5.46 5.73 5.63 5.74 5.52 4.49 5.36 4.53
Price to Earnings (P/E)
30.08 31.50 33.34 31.70 32.23 31.56 31.01 28.79 22.58 26.03 21.97
Dividend Yield
1.37% 1.29% 1.22% 1.29% 1.23% 1.26% 1.22% 1.25% 1.54% 1.27% 1.49%
Earnings Yield
3.32% 3.17% 3.00% 3.15% 3.10% 3.17% 3.22% 3.47% 4.43% 3.84% 4.55%
Enterprise Value to Invested Capital (EV/IC)
5.92 6.13 6.41 6.25 6.41 6.15 6.20 6.42 5.02 6.01 5.21
Enterprise Value to Revenue (EV/Rev)
5.23 5.54 5.86 5.51 5.78 5.68 5.79 5.48 4.48 5.36 4.56
Enterprise Value to EBITDA (EV/EBITDA)
16.63 17.61 18.73 17.72 18.29 18.06 18.10 16.83 13.42 15.62 13.28
Enterprise Value to EBIT (EV/EBIT)
23.47 24.74 26.31 24.96 25.53 25.22 24.95 22.89 18.02 20.70 17.55
Enterprise Value to NOPAT (EV/NOPAT)
30.40 32.07 34.18 32.55 33.34 32.91 32.35 29.43 23.23 26.78 22.75
Enterprise Value to Operating Cash Flow (EV/OCF)
27.61 27.89 25.14 21.50 24.57 24.10 24.61 20.29 16.80 18.64 14.59
Enterprise Value to Free Cash Flow (EV/FCFF)
66.96 66.15 49.42 41.78 53.90 52.68 53.43 35.42 32.71 33.17 24.58
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.15 0.15 0.14 0.08 0.07 0.08 0.08 0.00 0.01 0.01 0.04
Long-Term Debt to Equity
0.15 0.15 0.14 0.03 0.03 0.03 0.04 0.00 0.01 0.01 0.04
Financial Leverage
0.14 0.15 0.17 0.11 0.09 0.10 0.09 0.00 0.02 0.03 0.05
Leverage Ratio
1.70 1.65 1.62 1.65 1.58 1.53 1.49 1.50 1.46 1.43 1.43
Compound Leverage Factor
1.71 1.67 1.65 1.71 1.64 1.59 1.53 1.54 1.51 1.47 1.47
Debt to Total Capital
12.86% 12.88% 12.32% 7.53% 6.78% 7.06% 7.70% 0.00% 0.91% 0.90% 4.05%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 4.52% 4.36% 4.23% 4.08% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
12.86% 12.88% 12.32% 3.01% 2.42% 2.82% 3.63% 0.00% 0.91% 0.90% 4.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
87.14% 87.12% 87.68% 92.47% 93.22% 92.94% 92.30% 100.00% 99.09% 99.10% 95.95%
Debt to EBITDA
0.37 0.37 0.36 0.22 0.20 0.21 0.23 0.00 0.02 0.02 0.10
Net Debt to EBITDA
0.32 0.34 0.32 0.16 0.14 0.17 0.18 0.00 -0.02 -0.01 0.08
Long-Term Debt to EBITDA
0.37 0.37 0.36 0.09 0.07 0.08 0.11 0.00 0.02 0.02 0.10
Debt to NOPAT
0.67 0.68 0.67 0.40 0.36 0.38 0.41 0.00 0.04 0.04 0.18
Net Debt to NOPAT
0.59 0.61 0.59 0.30 0.25 0.32 0.31 0.00 -0.03 -0.02 0.14
Long-Term Debt to NOPAT
0.67 0.68 0.67 0.16 0.13 0.15 0.19 0.00 0.04 0.04 0.18
Altman Z-Score
8.55 9.35 10.16 9.08 10.17 10.70 11.50 11.18 10.12 11.94 10.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.20 1.37 1.39 1.00 1.11 1.17 1.36 1.27 1.49 1.60 1.74
Quick Ratio
0.68 0.74 0.78 0.59 0.61 0.62 0.74 0.78 0.79 0.85 0.89
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-98 -101 -30 15 -33 -53 -55 49 3.98 26 83
Operating Cash Flow to CapEx
325.70% 138.80% 188.32% 353.40% 212.31% 148.89% 191.86% 602.24% 243.11% 315.40% 290.50%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.80 0.81 0.81 0.78 0.79 0.80 0.81 0.80 0.81 0.83 0.84
Accounts Receivable Turnover
7.91 8.36 8.73 6.38 7.54 8.21 8.50 7.30 7.88 8.47 8.91
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 127.90 0.00 0.00
Fixed Asset Turnover
10.31 10.58 10.54 10.53 10.82 10.53 10.61 10.90 11.60 11.16 11.55
Accounts Payable Turnover
61.07 78.94 62.97 58.44 64.74 63.00 67.66 50.87 71.49 67.42 85.93
Days Sales Outstanding (DSO)
46.17 43.67 41.81 57.19 48.40 44.46 42.92 50.02 46.35 43.07 40.96
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.85 0.00 0.00
Days Payable Outstanding (DPO)
5.98 4.62 5.80 6.25 5.64 5.79 5.40 7.18 5.11 5.41 4.25
Cash Conversion Cycle (CCC)
40.19 39.05 36.01 50.94 42.76 38.66 37.53 42.84 44.09 37.66 36.71
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,873 1,953 2,003 1,954 2,022 2,100 2,167 2,029 2,157 2,195 2,204
Invested Capital Turnover
1.20 1.16 1.13 1.16 1.15 1.12 1.11 1.19 1.16 1.15 1.15
Increase / (Decrease) in Invested Capital
199 192 116 83 148 147 164 75 135 95 38
Enterprise Value (EV)
11,095 11,978 12,841 12,215 12,968 12,914 13,441 13,017 10,836 13,199 11,475
Market Capitalization
10,882 11,750 12,618 12,103 12,871 12,790 13,311 13,119 10,853 13,207 11,405
Book Value per Share
$22.76 $23.68 $24.43 $25.27 $26.40 $27.08 $27.94 $29.26 $29.82 $30.44 $29.58
Tangible Book Value per Share
$2.70 $3.54 $4.24 $5.02 $6.09 $6.72 $7.51 $8.80 $8.69 $9.16 $8.21
Total Capital
1,905 1,979 2,030 1,992 2,065 2,126 2,206 2,131 2,193 2,223 2,225
Total Debt
245 255 250 150 140 150 170 0.00 20 20 90
Total Long-Term Debt
245 255 250 60 50 60 80 0.00 20 20 90
Net Debt
214 228 223 112 97 124 130 -102 -16 -8.22 69
Capital Expenditures (CapEx)
48 59 52 66 55 60 56 54 50 48 64
Debt-free, Cash-free Net Working Capital (DFCFNWC)
61 124 120 50 111 147 208 44 179 203 233
Debt-free Net Working Capital (DFNWC)
93 150 148 88 154 172 248 146 216 231 254
Net Working Capital (NWC)
93 150 148 -1.80 64 82 158 146 216 231 254
Net Nonoperating Expense (NNE)
-0.42 -0.96 -1.58 -3.69 -4.20 -3.36 -2.48 -3.39 -4.73 -3.83 -2.71
Net Nonoperating Obligations (NNO)
214 228 223 112 97 124 130 -102 -16 -8.22 69
Total Depreciation and Amortization (D&A)
49 50 50 51 50 52 51 51 52 53 54
Debt-free, Cash-free Net Working Capital to Revenue
2.90% 5.72% 5.49% 2.25% 4.93% 6.46% 8.96% 1.84% 7.41% 8.22% 9.27%
Debt-free Net Working Capital to Revenue
4.38% 6.95% 6.74% 3.98% 6.85% 7.58% 10.67% 6.13% 8.91% 9.37% 10.09%
Net Working Capital to Revenue
4.38% 6.95% 6.74% -0.08% 2.84% 3.63% 6.79% 6.13% 8.91% 9.37% 10.09%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.40 $1.26 $1.20 $1.38 $1.63 $1.34 $1.53 $1.75 $1.98 $1.73 $1.71
Adjusted Weighted Average Basic Shares Outstanding
72.87M 72.84M 72.87M 72.87M 72.91M 72.92M 72.85M 72.87M 72.75M 72.27M 71.77M
Adjusted Diluted Earnings per Share
$1.39 $1.26 $1.19 $1.39 $1.63 $1.34 $1.52 $1.75 $1.97 $1.72 $1.71
Adjusted Weighted Average Diluted Shares Outstanding
73.01M 72.98M 73.03M 73.03M 73.08M 73.08M 73.01M 73.05M 72.91M 72.41M 71.98M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
72.83M 72.87M 72.90M 72.91M 72.96M 72.90M 72.82M 72.87M 72.38M 72.17M 71.05M
Normalized Net Operating Profit after Tax (NOPAT)
101 91 86 97 115 94 109 124 139 121 120
Normalized NOPAT Margin
17.72% 16.68% 15.88% 17.39% 19.13% 16.46% 18.57% 20.18% 21.60% 19.51% 18.89%
Pre Tax Income Margin
23.32% 22.03% 21.20% 23.29% 26.09% 22.20% 24.25% 25.99% 29.52% 26.51% 24.92%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
41.29% 40.62% 40.60% 40.83% 39.60% 39.57% 37.87% 36.13% 34.69% 33.20% 32.68%
Augmented Payout Ratio
53.73% 52.69% 45.89% 48.17% 41.61% 45.77% 47.91% 43.82% 54.89% 61.43% 87.46%

Financials Breakdown Chart

Key Financial Trends

Here are the notable trends for Jack Henry & Associates (JKHY) based on the last four fiscal years of quarterly statements (2022–2026). The focus is on how the company has evolved across revenue, profitability, cash flows, and balance-sheet fundamentals.

  • Revenue has stayed large and broadly rising, with multiple quarters above $600 million. Examples include 2025 Q1 revenue of $644.7M and 2026 Q1 revenue of $644.7M, with 2025 Q4 at $615.4M and 2026 Q2 at $619.3M, indicating sustained scale versus earlier years around the mid-$500M range.
  • Net income and profit margins have remained solid and generally trending higher, supported by consistent operating performance. Net income continuing operations ran around $111–145M across recent quarters, with 2025–2026 periods showing notable profitability (e.g., 2025 Q4 around $127.6M; 2026 Q1 around $144.0M; 2026 Q2 around $124.7M).
  • Operating margins are in a healthy range, roughly mid-20s percent. For example, 2026 Q2 shows Total Operating Income of $159.1M on revenue of $619.3M, implying an operating margin near 25.7%.
  • Operating cash flow is robust and growing, supporting sustaining capital returns to shareholders. Net cash from continuing operating activities was about $120.6M in 2026 Q1 and rose to $152.7M in 2026 Q2, reflecting strong cash generation relative to reported earnings.
  • Balance sheet composition is solid, with ample equity versus liabilities and a modest debt footprint. Total assets around $3.0B and total equity near $2.0B (e.g., 2026 Q2: Total Assets ~$3.06B, Total Equity ~$2.20B), with long-term debt generally in the tens of millions (e.g., 2025 Q4 long-term debt around $60M; 2026 Q2 around $20M).
  • R&D and selling, general, and administrative (SGA) costs are steady, leaving room for ongoing investment. R&D expenses typically run in the 6–7% range of revenue, while SG&A runs around 10–11% in many quarters, indicating ongoing investment in growth while preserving margins.
  • Financing cash flows are often negative due to debt repayments and shareholder returns, which reduces cash on hand even as CFO remains positive. For example, net cash from financing activities has frequently been negative in multiple periods, reflecting debt repayments and share repurchases/dividends.
  • Investing cash flows are consistently negative as the company funds capex and acquisitions, which suppresses free cash flow in the short term. Net cash from continuing investing activities is frequently negative (e.g., notable quarterly outflows for property, plant & equipment and acquisitions), reflecting ongoing capital investments.
05/14/26 11:42 AM ETAI Generated. May Contain Errors.

Jack Henry & Associates Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Jack Henry & Associates' financial year ends in June. Their financial year 2025 ended on June 30, 2025.

Jack Henry & Associates' net income appears to be on an upward trend, with a most recent value of $455.75 million in 2025, rising from $211.22 million in 2015. The previous period was $381.82 million in 2024. View Jack Henry & Associates' forecast to see where analysts expect Jack Henry & Associates to go next.

Jack Henry & Associates' total operating income in 2025 was $568.72 million, based on the following breakdown:
  • Total Gross Profit: $1.01 billion
  • Total Operating Expenses: $445.83 million

Over the last 10 years, Jack Henry & Associates' total revenue changed from $1.26 billion in 2015 to $2.38 billion in 2025, a change of 89.1%.

Jack Henry & Associates' total liabilities were at $913.14 million at the end of 2025, a 15.6% decrease from 2024, and a 8.0% increase since 2015.

In the past 10 years, Jack Henry & Associates' cash and equivalents has ranged from $0.00 in 2017 to $213.35 million in 2020, and is currently $101.95 million as of their latest financial filing in 2025.

Over the last 10 years, Jack Henry & Associates' book value per share changed from 12.24 in 2015 to 29.26 in 2025, a change of 139.0%.



Financial statements for NASDAQ:JKHY last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners